News and Announcements
Clinical Practice Guidelines Initiative is pleased to announce the completion of several guideline projects
July 12, 2016
Clinical Practice Guidelines Initiative is pleased to announce the completion of several guideline projects which are now available on CancerCare Manitoba?s (CCMBs) website.
Following are the four newly posted guidelines:
These guidelines can be used by administrators, clinicians and patients to determine the best course of action when decisions about treatment options or care must be made. The ultimate goal is to ease the patient's journey through the cancer experience and keep patients and their families at the centre of care.
CancerCare Manitoba?s website contains all approved Clinical Practice Guidelines (CPGs), Clinical Guides, and Systemic Therapy Summaries (STSs). Information on the development of our Clinical Practice Guidelines and other resources are also available.
Clinical Practice Guidelines and practice tool may be updated periodically. We recommend that practitioners frequently consult the website to ensure they are using the most recent versions.
We would like to extend a sincere thank you to all of the contributors listed in the guidelines for their time and expertise.
Increased Funding For Intravenous Cancer Drugs Will Support Manitobans Fighting Cancer: Premier
June 6, 2016
Budget 2016 includes an additional $4 million in funding to support the provision of cancer drugs for patients across the province, Premier Brian Pallister announced today.
"The national work to ensure affordability is significant because there are many new drugs being developed and it is anticipated that cancer drug costs will continue to rise," said Pallister. "We are committed to working with other stakeholders to look at ways to strengthen our system and improve the affordability, accessibility, appropriate prescribing and use of prescription drugs, both across the country and here at home."
The Provincial Oncology Drug Program includes funding for all intravenous drugs provided for cancer patients provincewide.
"Cancer is the leading cause of death in Manitoba. However, thanks to research, innovative treatments and new drugs, the cure rate for cancer is steadily improving," said Dr. Sri Navaratnam, president and CEO, CancerCare Manitoba. "We are very lucky that Manitobans with cancer are able to receive the intravenous drugs they need, whether at CancerCare, at regional cancer hubs or in their own home, at no cost to them."
CancerCare Manitoba administers the Provincial Oncology Drug Program, purchasing the drugs centrally and undertaking comprehensive reviews of new drugs or medications to determine if they will be introduced for use in Manitoba.
The additional funding will bring the budgeted amount for providing intravenous cancer drugs to approximately $50 million annually, the premier said, adding that Manitoba?s Home Cancer Drug Program provides cost-free access to approved oral cancer medications and cancer support drugs including anti-nausea medications that counter side-effects of chemotherapy.
The premier also said Manitoba is working with other provinces and territories to look at ways to ensure the long-term affordability of cancer drugs.
"Every year, cancer steals mothers from their children, husbands from their wives and friends from each other," said Health, Seniors and Active Living Minister Kelvin Goertzen. "By continuing to increase our investments in cancer drugs, we help fight this terrible disease and support health-care providers working to keep our loved ones with us longer."
Click here to view News Archive